174 related articles for article (PubMed ID: 10873458)
21. Lipoarabinomannans: from structure to biosynthesis.
Nigou J; Gilleron M; Puzo G
Biochimie; 2003; 85(1-2):153-66. PubMed ID: 12765785
[TBL] [Abstract][Full Text] [Related]
22. Lipid-restricted recognition of mycobacterial lipoglycans by human pulmonary surfactant protein A: a surface-plasmon-resonance study.
Sidobre S; Puzo G; Rivière M
Biochem J; 2002 Jul; 365(Pt 1):89-97. PubMed ID: 12071842
[TBL] [Abstract][Full Text] [Related]
23. Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses.
Afonso-Barroso A; Clark SO; Williams A; Rosa GT; Nóbrega C; Silva-Gomes S; Vale-Costa S; Ummels R; Stoker N; Movahedzadeh F; van der Ley P; Sloots A; Cot M; Appelmelk BJ; Puzo G; Nigou J; Geurtsen J; Appelberg R
Cell Microbiol; 2013 Apr; 15(4):660-74. PubMed ID: 23121245
[TBL] [Abstract][Full Text] [Related]
24. Structural definition of arabinomannans from Mycobacterium bovis BCG.
Nigou J; Gilleron M; Brando T; Vercellone A; Puzo G
Glycoconj J; 1999 Jun; 16(6):257-64. PubMed ID: 10579694
[TBL] [Abstract][Full Text] [Related]
25. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium.
Khoo KH; Dell A; Morris HR; Brennan PJ; Chatterjee D
J Biol Chem; 1995 May; 270(21):12380-9. PubMed ID: 7759478
[TBL] [Abstract][Full Text] [Related]
26. Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates.
Delmas C; Gilleron M; Brando T; Vercellone A; Gheorghui M; Rivière M; Puzo G
Glycobiology; 1997 Sep; 7(6):811-7. PubMed ID: 9376683
[TBL] [Abstract][Full Text] [Related]
27. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan.
Maeda N; Nigou J; Herrmann JL; Jackson M; Amara A; Lagrange PH; Puzo G; Gicquel B; Neyrolles O
J Biol Chem; 2003 Feb; 278(8):5513-6. PubMed ID: 12496255
[TBL] [Abstract][Full Text] [Related]
28. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production.
Garton NJ; Gilleron M; Brando T; Dan HH; Giguère S; Puzo G; Prescott JF; Sutcliffe IC
J Biol Chem; 2002 Aug; 277(35):31722-33. PubMed ID: 12072437
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium tuberculosis phoP mutant: lipoarabinomannan molecular structure.
Ludwiczak P; Gilleron M; Bordat Y; Martin C; Gicquel B; Puzo G
Microbiology (Reading); 2002 Oct; 148(Pt 10):3029-3037. PubMed ID: 12368436
[TBL] [Abstract][Full Text] [Related]
30. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains.
Chatterjee D; Lowell K; Rivoire B; McNeil MR; Brennan PJ
J Biol Chem; 1992 Mar; 267(9):6234-9. PubMed ID: 1556132
[TBL] [Abstract][Full Text] [Related]
31. Application of capillary electrophoresis mass spectrometry to the characterization of bacterial lipopolysaccharides.
Li J; Richards JC
Mass Spectrom Rev; 2007; 26(1):35-50. PubMed ID: 16967446
[TBL] [Abstract][Full Text] [Related]
32. The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2.
Gilleron M; Nigou J; Nicolle D; Quesniaux V; Puzo G
Chem Biol; 2006 Jan; 13(1):39-47. PubMed ID: 16426970
[TBL] [Abstract][Full Text] [Related]
33. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties.
Guérardel Y; Maes E; Briken V; Chirat F; Leroy Y; Locht C; Strecker G; Kremer L
J Biol Chem; 2003 Sep; 278(38):36637-51. PubMed ID: 12829695
[TBL] [Abstract][Full Text] [Related]
34. Mannosylated lipoarabinomannan interacts with phagocytes.
Venisse A; Fournié JJ; Puzo G
Eur J Biochem; 1995 Jul; 231(2):440-7. PubMed ID: 7635156
[TBL] [Abstract][Full Text] [Related]
35. Capillary affinity electrophoresis using lectins for the analysis of milk oligosaccharide structure and its application to bovine colostrum oligosaccharides.
Nakajima K; Kinoshita M; Matsushita N; Urashima T; Suzuki M; Suzuki A; Kakehi K
Anal Biochem; 2006 Jan; 348(1):105-14. PubMed ID: 16289347
[TBL] [Abstract][Full Text] [Related]
36. Analysis of mycobacterial strains by two-dimensional gel electrophoresis.
Bisht D; Singhal N; Sharma P; Venkatesan K
J Commun Dis; 2006 Mar; 38(3):255-62. PubMed ID: 17373357
[TBL] [Abstract][Full Text] [Related]
37. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure and functional implications of LprF from Mycobacterium tuberculosis and M. bovis.
Kim JS; Jiao L; Oh JI; Ha NC; Kim YH
Acta Crystallogr D Biol Crystallogr; 2014 Oct; 70(Pt 10):2619-30. PubMed ID: 25286846
[TBL] [Abstract][Full Text] [Related]
39. Tsukamurella paurometabola lipoglycan, a new lipoarabinomannan variant with pro-inflammatory activity.
Gibson KJ; Gilleron M; Constant P; Brando T; Puzo G; Besra GS; Nigou J
J Biol Chem; 2004 May; 279(22):22973-82. PubMed ID: 15031299
[TBL] [Abstract][Full Text] [Related]
40. MS/MS approach for characterization of the fatty acid distribution on mycobacterial phosphatidyl-myo-inositol mannosides.
Gilleron M; Lindner B; Puzo G
Anal Chem; 2006 Dec; 78(24):8543-8. PubMed ID: 17165851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
